In new patients, disability score changes were similar over 2 years regardless of treatmen ...

MS medications can help slow the disease and manage symptoms. Interferon beta injectable drugs stop white blood cells from harming the brain and spinal cord. Natalizumab is a special protein that ...

In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in meaningful improvements in fatigue, a ...

Although there is currently no cure for multiple sclerosis (MS), current treatments focus on limiting further damage, easing symptoms, and avoiding complications. If you have a type of multiple ...

U.S. Multiple Sclerosis Drugs Market to Reach USD 20.89 Billion and Europe USD 15.51 Billion by 2035 as Monoclonal Antibody Therapies and Personalized Neurology Solutions Drive Demand.Austin, United ...

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...

MS fatigue in relapsing-remitting disease was linked to pain, sleep problems, anxiety, stress, and disability in a ...

Research puts the number of Americans living with MS at roughly one million, with about 2.9 million affected worldwide. The FDA's sign-off on Quantum BioPharma's Investigational New Drug (“IND”) ...

A seizure can be scary. And when you’re already living with multiple sclerosis (MS), it’s easy to wonder whether the episode could somehow be related — and if you now have a new symptom you’ll need to ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...

In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in meaningful improvements in fatigue, a ...